CNS tuberculoma in an immunocompetent patient: A case report of multi-drug hypersensitivity to RIPE therapy

BACKGROUND: Tuberculosis (TB) is the second leading cause of death due to an infectious disease worldwide (World Health Organization, 2022 [1]). The first line treatment of TB involves the concurrent use of four drugs: rifampin, isoniazid, pyrazinamide, and ethambutol (RIPE). Given the rising threat...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Benjamin, Joshi, Seema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477797/
https://www.ncbi.nlm.nih.gov/pubmed/37674901
http://dx.doi.org/10.1016/j.idcr.2023.e01886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477797/
https://www.ncbi.nlm.nih.gov/pubmed/37674901
http://dx.doi.org/10.1016/j.idcr.2023.e01886

Ejemplares similares